Problems in learning, memory and other complex mental processes are common to many brain disorders. This project will study the impact of mutations on a family of genes reported in autism and schizophrenia, on complex cognitive behaviours using novel behavioural technologies. This will not only shed fundamental insights into the specific mental processes regulated by these genes and their role in disease, but importantly provide novel targets for the development of therapies.
The majority of stroke results from focal brain infarction, followed by substantial secondary excitotoxic damage in the surrounding areas. Tau has been shown to contribute to excitotoxicity and neurodegeneration in mouse models of Alzheimer’s disease (AD). Preliminary data show that tau reduction also protects against excitotoxic damage after experimental stroke. We aim to dissect the molecular mechanisms of stroke using a tau-deficient mouse model.
Effects Of Melanocortin Neurons On Systemic Glucose Homeostasis
Funder
National Health and Medical Research Council
Funding Amount
$860,251.00
Summary
There is good evidence that the brain can control blood glucose, but we do not know how this occurs, or why this doesn’t work in diabetes. This grant will use cutting edge mouse genetic technology to determine how the brain controls blood glucose, and what changes in diabetes. This grant will determine how several hormones act through the brain to change glucose levels, and will help develop new strategies to treat high blood glucose.